What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Bioresorbable Stents Market to Reach $618.8 Million by 2026

Bioresorbable stents represent the latest innovation in angioplasty, the medical procedure wherein a round, tubular, metallic stent is inserted into a clogged artery to open it up and enhance the flow of blood. Technological advancements, over the years, have led to the development of bioresorbable scaffolds made up of polyactides. Also referred to as dissolving stents, biodegradable stents or bioresorbable scaffolds, bioabsorbable stents without any permanent implant, gets resorbed in the body and eventually completely disappear from the body. Bioabsorbable stents have emerged as a successful alternative to the conventional metallic stents that remain permanently in the body, and often cause issues such as late-stent thrombosis, in-stent restenosis and needs antiplatelet therapy for long-term in some patients. Metallic stents may also impede with MRI and CT imaging, and also avert chances of coronary bypass graft surgery. Since, bioabsorbable stents completely dissolve and disappear from the blood vessel following 2 - 4 years of placement, the risks often associated with metallic or drug-eluting stents are also eliminated. As the stent disappears from the artery, the vessel returns to its natural state, resulting in the return of vasoconstriction and vasodilatation.

Growth in the global market is set to be fueled by increasing prevalence of cardiovascular diseases such as peripheral artery and coronary artery diseases, increasing elderly population, and fast increasing obese population. Additional growth factors include an increase in number of PCI procedures performed each year, more patients favoring minimally invasive therapies, higher adoption of these stents by patients and physicians alike, and greater number of clinical trials evaluating the use of bioabsorbable stents. The popularity of bioabsorbable stents is influenced by the elimination of the need to perform stent-in-stent procedures, elimination of the requirement for dual anti-platelet therapies, higher degree of effectiveness in treating coronary artery diseases, and the possibility of achieving accurate stent placement as well as cost-effectiveness of the treatment.

Amid the COVID-19 crisis, the global market for Bioresorbable Stents estimated at US$390.2 Million in the year 2022, is projected to reach a revised size of US$618.8 Million by 2026, growing at a CAGR of 11.8% over the analysis period. Polymer-based Bioresorbable Stents, one of the segments analyzed in the report, is projected to reach US$499.5 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Metal-based Bioresorbable Stents segment is readjusted to a revised 10% CAGR for the next 7-year period. Bioabsorbable polymer stents represent the largest segment as these stents are made using materials that get completely dissolved in the body, and hence find use in procedures with respect to both coronary artery and peripheral artery diseases. Metal-based bioresorbable scaffolds, such as magnesium and iron, are preferred over polymer-based biodegradable stents, due to their superior performance. Magnesium-based bioabsorbable stents minimize thrombogenicity and cause rapid endothelialization, and involve a lesser degradation period.

European Market is Estimated at $213.6 Million in 2022, While Asia-Pacific is Forecast to Reach $159.8 Million by 2026

Bioresorbable Stents market in Europe is estimated at US$213.6 Million in the year 2022. Asia-Pacific is forecast to reach a projected market size of US$159.8 Million by the year 2026 trailing a CAGR of 10.3% over the analysis period. Rest of World is forecast to grow at 11.1% over the analysis period. Europe represents the largest regional market and growth in the region is being spurred by higher prevalence of cardiovascular diseases, an aging population at risk of these diseases, greater awareness with regard to and increased adoption of bioabsorbable stents. The significant demand for technologically advanced treatments for cardiovascular problems boosts usage of bioresorbable stents. Growing awareness with respect to peripheral and coronary artery diseases and an increase in number of people with higher cholesterol levels, a major risk factor for cardiovascular diseases, is helping the demand expand for bioabsorbable stents in Asia-Pacific region.